← FDA Drug Approvals (Drugs@FDA)

AURLUMYN

NDA · New Drug Application · Sponsor: BTG INTL · Approved 2024-02-13

Drug application

FDA Application #

NDA217933

Application type

New Drug Application

Brand name

AURLUMYN

Generic name

ILOPROST

Active ingredients

ILOPROST

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BTG INTL

Manufacturer

BTG International Inc

First approval

2024-02-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown